Cargando…
Soluble CD40 in plasma and malignant pleural effusion with non-small cell lung cancer: A potential marker of prognosis
OBJECTIVE: Soluble CD40 (sCD40) is a potential modulator for both antitumor responses and CD40-based immunotherapy; however the levels and significance of sCD40 in non-small cell lung cancer (NSCLC) patients with malignant pleural effusion are unknown. METHODS: Forty-eight patients with lung cancer...
Autores principales: | Mu, Chuan-Yong, Qin, Pang-Xue, Qu, Qiu-Xia, Chen, Cheng, Huang, Jian-An |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643771/ https://www.ncbi.nlm.nih.gov/pubmed/29062985 http://dx.doi.org/10.1016/j.cdtm.2015.02.010 |
Ejemplares similares
-
Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma
por: Augeri, Stefania, et al.
Publicado: (2018) -
Profile of soluble factors in pleural effusions predict prognosis in mesothelioma
por: Dick, I.M., et al.
Publicado: (2022) -
Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions
por: Wang, Maoshui, et al.
Publicado: (2014) -
Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions
por: Gao, Jinying, et al.
Publicado: (2019) -
mRNA markers associated with malignant pleural effusion
por: Hsu, Shih-Chang, et al.
Publicado: (2023)